Fresenius Kabi is correcting Ivenix LVP software due to anomalies that could cause serious patient harm or death
Similar Posts
FDA In Brief: FDA issues 57 product-specific guidances, including 19 laying out path for developing generics to hard-to-copy “complex” medicines
FDA is posting 57 product-specific guidances to help industry generate evidence needed to support approval of generic drug applicationsCohance Lifesciences Limited – 8/12/2025
Cohance Lifesciences Limited – 8/12/2025. Country: India. Record Type: 483Caspofungin Injection
Caspofungin InjectionMedical Gases — Current Good Manufacturing Practice
Pharmaceutical Quality/Manufacturing Standards (CGMP)Alert: Automated Impella Controller Correction due to Cybersecurity Issue from Abiomed
Abiomed has issued a letter to affected customers of cybersecurity vulnerabilities related to the operating system in the Automated Impella ControllerFDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
The FDA granted supplemental approval to Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.